Santen Pharmaceutical Statistics
Total Valuation
SNPHF has a market cap or net worth of 3.23 billion. The enterprise value is 2.70 billion.
| Market Cap | 3.23B |
| Enterprise Value | 2.70B |
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025.
| Earnings Date | May 13, 2025 |
| Ex-Dividend Date | Sep 27, 2024 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -4.34% |
| Shares Change (QoQ) | -1.90% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 329.76M |
Valuation Ratios
The trailing PE ratio is 18.46.
| PE Ratio | 18.46 |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.19, with an EV/FCF ratio of 9.18.
| EV / Earnings | 15.43 |
| EV / Sales | 1.33 |
| EV / EBITDA | 6.19 |
| EV / EBIT | 8.59 |
| EV / FCF | 9.18 |
Financial Position
The company has a current ratio of 2.61
| Current Ratio | 2.61 |
| Quick Ratio | 1.87 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 43.93 |
Financial Efficiency
Return on equity (ROE) is 9.45% and return on invested capital (ROIC) is 11.02%.
| Return on Equity (ROE) | 9.45% |
| Return on Assets (ROA) | 7.75% |
| Return on Invested Capital (ROIC) | 11.02% |
| Return on Capital Employed (ROCE) | 16.02% |
| Revenue Per Employee | 512,893 |
| Profits Per Employee | 46,708 |
| Employee Count | 3,744 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 2.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +10.75% in the last 52 weeks. The beta is 0.10, so SNPHF's price volatility has been lower than the market average.
| Beta (5Y) | 0.10 |
| 52-Week Price Change | +10.75% |
| 50-Day Moving Average | 10.20 |
| 200-Day Moving Average | 8.39 |
| Relative Strength Index (RSI) | 48.59 |
| Average Volume (20 Days) | 728 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SNPHF had revenue of 1.92 billion and earned 174.88 million in profits. Earnings per share was 0.49.
| Revenue | 1.92B |
| Gross Profit | 1.10B |
| Operating Income | 325.80M |
| Pretax Income | 201.14M |
| Net Income | 174.88M |
| EBITDA | 440.99M |
| EBIT | 325.80M |
| Earnings Per Share (EPS) | 0.49 |
Balance Sheet
The company has 495.17 million in cash and n/a in debt, giving a net cash position of 495.17 million.
| Cash & Cash Equivalents | 495.17M |
| Total Debt | n/a |
| Net Cash | 495.17M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 1.80B |
| Book Value Per Share | 5.29 |
| Working Capital | 805.30M |
Cash Flow
In the last 12 months, operating cash flow was 351.40 million and capital expenditures -57.54 million, giving a free cash flow of 293.86 million.
| Operating Cash Flow | 351.40M |
| Capital Expenditures | -57.54M |
| Free Cash Flow | 293.86M |
| FCF Per Share | n/a |
Margins
Gross margin is 57.17%, with operating and profit margins of 16.97% and 9.11%.
| Gross Margin | 57.17% |
| Operating Margin | 16.97% |
| Pretax Margin | 10.47% |
| Profit Margin | 9.11% |
| EBITDA Margin | 22.96% |
| EBIT Margin | 16.97% |
| FCF Margin | 15.30% |
Dividends & Yields
This stock pays an annual dividend of 0.12, which amounts to a dividend yield of 1.12%.
| Dividend Per Share | 0.12 |
| Dividend Yield | 1.12% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 44.13% |
| Buyback Yield | 4.34% |
| Shareholder Yield | 5.45% |
| Earnings Yield | 5.42% |
| FCF Yield | 9.10% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SNPHF has an Altman Z-Score of 5.39.
| Altman Z-Score | 5.39 |
| Piotroski F-Score | n/a |